Business question from Sandra Gidley (Liberal Democrat) in the House of Commons on Thursday, 9 December 2004. It occurred during Business statement on Leader of the House of Commons.
Leader of the House of Commons
Supplementary business question on the prescribing of selective serotonin reuptake inhibitor drugs including anti-depressants such as seroxat.
Secondary information
- Type
- Proceeding contribution
- Reference
- 428 c1284
- Session
- 2004-05
- Chamber / Committee
- House of Commons chamber
- Subjects
- Prescription drugs Side effects Paroxetine Antidepressants Dental services Africa Hospitals Disease control Hygiene Foreign relations NHS MRSA Middle East
- Legislation
- Constitutional Reform Bill (HL) 2003/04 to 2004/05
- Link
- View this Proceeding contribution on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-16 03:34:14 +0000
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/-question
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/-question
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_972216/-question